PATENT CLAIM ANALYSIS

Application Number: 16070024
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["435", "006130"]

Abstract:
Provided is a test method comprising a step for measuring the number of SSEA-3-positive pluripotent stem cells present in a blood sample collected from a subject, the test method providing a prognosis for cerebral infarction in the subject, and the diagnosis or prediction of asymptomatic cerebral infarction or the risk of cerebral infarction after a transient ischemic attack in the subject using the number of pluripotent stem cells as an index.

Claim (Index 8):
The screening method according to  claim 7 , further comprising a step for comparing with a cutoff value.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 95.0
- Lexical Diversity: 1.72093
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14421754', '15802899', '13435703', '15413129', '12740718']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5612181444009905
- 35 USC 102 Novelty (BERT): 0.5325493622458053
- Combined Prediction Score: 0.558351266185472
- Mean Citation Score: 269.746356
- Max Citation Score: 290.83658
- Similarity Product: 126.81963677528502

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test